OBJECTIVES: The purpose of this study was to determine whether obese individuals with reduced adipose tissue inflammation exhibit a more favorable cardiovascular risk profile. BACKGROUND: Obesity is associated with a low-grade state of chronic inflammation that might be causally related to cardiometabolic disease. METHODS: With immunohistochemistry, we categorized obese individuals dichotomously as having inflamed fat (n = 78) or noninflamed fat (n = 31) on the basis of the presence (+) or absence (-) of macrophage crown-like structures (CLS) in subcutaneous abdominal fat biopsy samples. We compared their metabolic, vascular, and adipose tissue characteristics with lean subjects (n = 17). RESULTS: Inflamed CLS+ obese individuals displayed higher plasma insulin, homeostasis model assessment, triglycerides, glucose, blood pressure, high-sensitivity C-reactive protein, low-density lipoprotein cholesterol, lower high-density lipoprotein cholesterol, and brachial artery flow-mediated dilation compared with lean subjects (p < 0.05). Adipose messenger ribonucleic acid expression of inflammatory genes including CD68, leptin, matrix metalloproteinase-9, CD163, and CD8A were significantly greater and vascular endothelial growth factor was lower in the CLS+ group (p < 0.05). In contrast, obese subjects with noninflamed fat exhibited a mixed clinical phenotype with lower insulin resistance, reduced proatherogenic gene expression, and preserved vascular function as in lean subjects. In multiple linear regression adjusting for age and sex, CLS status (beta = -0.28, p = 0.008) and waist circumference (beta = -0.25, p = 0.03) were independent predictors of flow-mediated dilation. CONCLUSIONS: These findings lend support to the novel concept that factors in addition to absolute weight burden, such as qualitative features of adipose tissue, might be important determinants of cardiovascular disease. Therapeutic modulation of the adipose phenotype might represent a target for treatment in obesity.
OBJECTIVES: The purpose of this study was to determine whether obese individuals with reduced adipose tissue inflammation exhibit a more favorable cardiovascular risk profile. BACKGROUND:Obesity is associated with a low-grade state of chronic inflammation that might be causally related to cardiometabolic disease. METHODS: With immunohistochemistry, we categorized obese individuals dichotomously as having inflamed fat (n = 78) or noninflamed fat (n = 31) on the basis of the presence (+) or absence (-) of macrophage crown-like structures (CLS) in subcutaneous abdominal fat biopsy samples. We compared their metabolic, vascular, and adipose tissue characteristics with lean subjects (n = 17). RESULTS: Inflamed CLS+ obese individuals displayed higher plasma insulin, homeostasis model assessment, triglycerides, glucose, blood pressure, high-sensitivity C-reactive protein, low-density lipoprotein cholesterol, lower high-density lipoprotein cholesterol, and brachial artery flow-mediated dilation compared with lean subjects (p < 0.05). Adipose messenger ribonucleic acid expression of inflammatory genes including CD68, leptin, matrix metalloproteinase-9, CD163, and CD8A were significantly greater and vascular endothelial growth factor was lower in the CLS+ group (p < 0.05). In contrast, obese subjects with noninflamed fat exhibited a mixed clinical phenotype with lower insulin resistance, reduced proatherogenic gene expression, and preserved vascular function as in lean subjects. In multiple linear regression adjusting for age and sex, CLS status (beta = -0.28, p = 0.008) and waist circumference (beta = -0.25, p = 0.03) were independent predictors of flow-mediated dilation. CONCLUSIONS: These findings lend support to the novel concept that factors in addition to absolute weight burden, such as qualitative features of adipose tissue, might be important determinants of cardiovascular disease. Therapeutic modulation of the adipose phenotype might represent a target for treatment in obesity.
Authors: P Dandona; P Mohanty; H Ghanim; A Aljada; R Browne; W Hamouda; A Prabhala; A Afzal; R Garg Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: Allison B Goldfine; Vivian Fonseca; Kathleen A Jablonski; Laura Pyle; Myrlene A Staten; Steven E Shoelson Journal: Ann Intern Med Date: 2010-03-16 Impact factor: 25.391
Authors: Jane E Freedman; Martin G Larson; Kahraman Tanriverdi; Christopher J O'Donnell; Kristine Morin; Amanda S Hakanson; Ramachandran S Vasan; Andrew D Johnson; Mark D Iafrati; Emelia J Benjamin Journal: Circulation Date: 2010-07-06 Impact factor: 29.690
Authors: Adam S Greenstein; Kaivan Khavandi; Sarah B Withers; Kazuhiko Sonoyama; Olivia Clancy; Maria Jeziorska; Ian Laing; Allen P Yates; Philip W Pemberton; Rayaz A Malik; Anthony M Heagerty Journal: Circulation Date: 2009-03-16 Impact factor: 29.690
Authors: David Reed Flum; Steven H Belle; Wendy C King; Abdus S Wahed; Paul Berk; William Chapman; Walter Pories; Anita Courcoulas; Carol McCloskey; James Mitchell; Emma Patterson; Alfons Pomp; Myrlene A Staten; Susan Z Yanovski; Richard Thirlby; Bruce Wolfe Journal: N Engl J Med Date: 2009-07-30 Impact factor: 91.245
Authors: Husam Ghanim; Sanaa Abuaysheh; Ching Ling Sia; Kelly Korzeniewski; Ajay Chaudhuri; Jose Manuel Fernandez-Real; Paresh Dandona Journal: Diabetes Care Date: 2009-09-15 Impact factor: 17.152
Authors: Magdalena Pasarica; Olga R Sereda; Leanne M Redman; Diana C Albarado; David T Hymel; Laura E Roan; Jennifer C Rood; David H Burk; Steven R Smith Journal: Diabetes Date: 2008-12-15 Impact factor: 9.461
Authors: S A Abbasi; W G Hundley; D A Bluemke; M Jerosch-Herold; R Blankstein; Steffen E Petersen; Oliver J Rider; J A C Lima; M A Allison; V L Murthy; R V Shah Journal: Nutr Metab Cardiovasc Dis Date: 2015-04-16 Impact factor: 4.222
Authors: Abigail S Haka; Erika Sue; Chi Zhang; Priya Bhardwaj; Joshua Sterling; Cassidy Carpenter; Madeline Leonard; Maryem Manzoor; Jeanne Walker; Jose O Aleman; Daniel Gareau; Peter R Holt; Jan L Breslow; Xi Kathy Zhou; Dilip Giri; Monica Morrow; Neil Iyengar; Ishan Barman; Clifford A Hudis; Andrew J Dannenberg Journal: Anal Chem Date: 2016-01-28 Impact factor: 6.986
Authors: Dequina A Nicholas; Guillaume Andrieu; Katherine J Strissel; Barbara S Nikolajczyk; Gerald V Denis Journal: Cell Mol Life Sci Date: 2016-08-04 Impact factor: 9.261
Authors: Adrian T Billeter; Spiros Vittas; Barbara Israel; Katharina M Scheurlen; Asa Hidmark; Thomas H Fleming; Stefan Kopf; Markus W Büchler; Beat P Müller-Stich Journal: Langenbecks Arch Surg Date: 2017-07-09 Impact factor: 3.445
Authors: Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki Journal: Ann Vasc Surg Date: 2013-04 Impact factor: 1.466
Authors: Elisa Fabbrini; Marina Cella; Steve A McCartney; Anja Fuchs; Nada A Abumrad; Terri A Pietka; Zhouji Chen; Brian N Finck; Dong Ho Han; Faidon Magkos; Caterina Conte; David Bradley; Gemma Fraterrigo; J Christopher Eagon; Bruce W Patterson; Marco Colonna; Samuel Klein Journal: Gastroenterology Date: 2013-04-15 Impact factor: 22.682